Jakarta - Delayed Quote IDR

PT Sarana Meditama Metropolitan Tbk (SAME.JK)

280.00
+4.00
+(1.45%)
At close: May 22 at 4:10:42 PM GMT+7
Loading Chart for SAME.JK
  • Previous Close 276.00
  • Open 274.00
  • Bid --
  • Ask --
  • Day's Range 274.00 - 280.00
  • 52 Week Range 186.00 - 340.00
  • Volume 540,400
  • Avg. Volume 1,279,803
  • Market Cap (intraday) 4.801T
  • Beta (5Y Monthly) 0.72
  • PE Ratio (TTM) 237.29
  • EPS (TTM) 1.18
  • Earnings Date Jul 30, 2025 - Aug 4, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date May 18, 2018
  • 1y Target Est --

PT Sarana Meditama Metropolitan Tbk engages in the hospital management of EMC Hospital Pulomas in Pulomas, East Jakarta. The company was founded in 1984 and is based in Jakarta, Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Elang Mahkota Teknologi Tbk.

www.emc.id

3,007

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SAME.JK

View More

Performance Overview: SAME.JK

Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is IDX COMPOSITE (^JKSE) .

YTD Return

SAME.JK
6.06%
IDX COMPOSITE (^JKSE)
1.23%

1-Year Return

SAME.JK
6.06%
IDX COMPOSITE (^JKSE)
0.77%

3-Year Return

SAME.JK
28.57%
IDX COMPOSITE (^JKSE)
3.60%

5-Year Return

SAME.JK
339.01%
IDX COMPOSITE (^JKSE)
57.66%

Compare To: SAME.JK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SAME.JK

View More

Valuation Measures

Annual
As of 5/21/2025
  • Market Cap

    4.73T

  • Enterprise Value

    5.55T

  • Trailing P/E

    235.90

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.76

  • Price/Book (mrq)

    1.25

  • Enterprise Value/Revenue

    3.25

  • Enterprise Value/EBITDA

    29.05

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    1.16%

  • Return on Assets (ttm)

    1.21%

  • Return on Equity (ttm)

    0.67%

  • Revenue (ttm)

    1.71T

  • Net Income Avi to Common (ttm)

    19.95B

  • Diluted EPS (ttm)

    1.18

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    73.29B

  • Total Debt/Equity (mrq)

    22.49%

  • Levered Free Cash Flow (ttm)

    -122.31B

Research Analysis: SAME.JK

View More

Company Insights: SAME.JK

Research Reports: SAME.JK

View More

People Also Watch